Sangamo Therapeutics receives Nasdaq delisting denial; bankruptcy court approves asset sale bidding procedures

SANGAMO THERAPEUTICS, INC

Bankruptcy court approved asset sale bidding procedures; bid deadline Aug 4, auction Aug 10, sale hearing Aug 20.
Nasdaq Hearings Panel denied listing continuation; company will not appeal; expects Form 25 delisting.
Stock suspended from Nasdaq since May 5, 2026; currently trades on OTCQB under symbol SGMOQ.
Company filed Chapter 11 on June 23, 2026; continues as debtor-in-possession under court jurisdiction.

Featured in Daily 8-K Digest

Selected #10 for 2026-07-20. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.